Related Experiment Video
Updated: Feb 27, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Synthetic lethality between the cohesin subunits STAG1 and STAG2 in diverse cancer contexts
Petra van der Lelij1, Simone Lieb2, Julian Jude1
1Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria.
Abstract:
Recent genome analyses have identified recurrent mutations in the cohesin complex in a wide range of human cancers. Here we demonstrate that the most frequently mutated subunit of the cohesin complex, STAG2, displays a strong synthetic lethal interaction with its paralog STAG1. Mechanistically, STAG1 loss abrogates sister chromatid cohesion in STAG2 mutated but not in wild-type cells leading to mitotic catastrophe, defective cell division and apoptosis. STAG1 inactivation inhibits the proliferation of STAG2 mutated but not wild-type bladder cancer and Ewing sarcoma cell lines. Restoration of STAG2 expression in a mutated bladder cancer model alleviates the dependency on STAG1. Thus, STAG1 and STAG2 support sister chromatid cohesion to redundantly ensure cell survival. STAG1 represents a vulnerability of cancer cells carrying mutations in the major emerging tumor suppressor STAG2 across different cancer contexts. Exploiting synthetic lethal interactions to target recurrent cohesin mutations in cancer, e.g. by inhibiting STAG1, holds the promise for the development of selective therapeutics.
Insights
Mutations in the STAG2 gene create a vulnerability that can be targeted by inhibiting STAG1. This synthetic lethal interaction causes cell death in cancer cells with STAG2 mutations, offering a potential new cancer therapy.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Biology
Background:
- Recurrent mutations in the cohesin complex are prevalent in human cancers.
- STAG2 is the most frequently mutated subunit within the cohesin complex.
Purpose of the Study:
- To investigate the functional consequences of STAG2 mutations.
- To identify therapeutic vulnerabilities associated with STAG2 mutations.
Main Methods:
- Analysis of synthetic lethal interactions between STAG1 and STAG2.
- Cell proliferation assays in cancer cell lines with varying STAG2 expression.
- Sister chromatid cohesion assays.
Main Results:
- STAG2 mutations lead to a synthetic lethal interaction with STAG1.
- Loss of STAG1 causes mitotic catastrophe and apoptosis specifically in STAG2-mutated cells.
- STAG1 inactivation inhibits proliferation in STAG2-mutated bladder cancer and Ewing sarcoma cells.
- Restoring STAG2 expression reduces the dependency on STAG1.
Conclusions:
- STAG1 and STAG2 redundantly maintain sister chromatid cohesion and cell survival.
- STAG1 is a critical vulnerability in cancers with STAG2 mutations.
- Targeting STAG1 via synthetic lethality offers a promising therapeutic strategy for cohesin-mutated cancers.
More Related Videos
Related Concept Videos
Cohesins
Cohesin complexes in Meiotic Division
Meiosis involves two distinct rounds of chromosomal segregation and cell divisions— Meiosis I followed by Meiosis II – producing four daughter cells. Meiosis I includes the separation of...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

